<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>21(12)</volume><submitter>Borovikov YS</submitter><pubmed_abstract>Substitution of Ala for Glu residue in position 173 of γ-tropomyosin (Tpm3.12) is associated with muscle weakness. Here we observe that this mutation increases myofilament Ca2+-sensitivity and inhibits in vitro actin-activated ATPase activity of myosin subfragment-1 at high Ca2+. In order to determine the critical conformational changes in myosin, actin and tropomyosin caused by the mutation, we used the technique of polarized fluorimetry. It was found that this mutation changes the spatial arrangement of actin monomers and myosin heads, and the position of the mutant tropomyosin on the thin filaments in muscle fibres at various mimicked stages of the ATPase cycle. At low Ca2+ the E173A mutant tropomyosin shifts towards the inner domains of actin at all stages of the cycle, and this is acc</pubmed_abstract><journal>International journal of molecular sciences</journal><pagination>E4421</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7352912</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Molecular Mechanisms of Muscle Weakness Associated with E173A Mutation in Tpm3.12. Troponin Ca2+ Sensitivity Inhibitor W7 Can Reduce the Damaging Effect of This Mutation.</pubmed_title><pmcid>PMC7352912</pmcid><pubmed_authors>Avrova SV</pubmed_authors><pubmed_authors>Simonyan AO</pubmed_authors><pubmed_authors>Redwood CS</pubmed_authors><pubmed_authors>Borovikov YS</pubmed_authors><pubmed_authors>Karpicheva OE</pubmed_authors><pubmed_authors>Sirenko VV</pubmed_authors></additional><is_claimable>false</is_claimable><name>Molecular Mechanisms of Muscle Weakness Associated with E173A Mutation in Tpm3.12. Troponin Ca2+ Sensitivity Inhibitor W7 Can Reduce the Damaging Effect of This Mutation.</name><description>Substitution of Ala for Glu residue in position 173 of γ-tropomyosin (Tpm3.12) is associated with muscle weakness. Here we observe that this mutation increases myofilament Ca2+-sensitivity and inhibits in vitro actin-activated ATPase activity of myosin subfragment-1 at high Ca2+. In order to determine the critical conformational changes in myosin, actin and tropomyosin caused by the mutation, we used the technique of polarized fluorimetry. It was found that this mutation changes the spatial arrangement of actin monomers and myosin heads, and the position of the mutant tropomyosin on the thin filaments in muscle fibres at various mimicked stages of the ATPase cycle. At low Ca2+ the E173A mutant tropomyosin shifts towards the inner domains of actin at all stages of the cycle, and this is acc</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-19T11:37:24.842Z</modification><creation>2025-04-19T11:37:24.842Z</creation></dates><accession>S-EPMC7352912</accession><cross_references><pubmed>32580284</pubmed><doi>10.3390/ijms21124421</doi></cross_references></HashMap>